Back to RGNX overview

RGNX REGENXBIO PE ratio, current and historical analysis

The current PE ratio of RGNX can't be determined, as the TTM EPS of -$5.87 is negative. The last PE ratio of REGENXBIO, recorded in September 2022, was 14.52.

RGNX PE ratio history

How has RGNX's PE ratio performed in the past

The PE ratio of REGENXBIO has averaged 17.2 over the last eight years. Over the past eight years, RGNX's PE ratio was at its highest in the Sep 2018 quarter at 29.49, when the stock price was $75.5 and the EPS was $2.56. The lowest value was in the Dec 2021 quarter, when it reached 10.86 with a price of $32.7 and an EPS of $3.01.

Average
17.2
Median
14.28
Minimum
10.86
Maximum
29.49

REGENXBIO PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 10.86 N/A
2020 N/A N/A
2019 N/A N/A
2018 14.03 N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

RGNX average PE ratio chart

What is the average PE ratio of RGNX for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

RGNX PE vs peers

What is RGNX's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $649.39M
OMER Omeros Corp N/A $228.88M
OMGA Omega Therapeutics Inc N/A $134.03M
RGNX REGENXBIO Inc N/A $591.07M

Frequently asked questions

What is REGENXBIO's PE ratio?

The current price to earnings ratio of RGNX can't be calculated, as its EPS of -$5.87 is negative.

What is the highest PE ratio for RGNX?

Over the last eight years, the quarterly PE ratio reached a historic high of 29.49 in the Sep 2018 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.